Regenerative Potential of Spermatogonial Stem Cells, Endothelial Progenitor Cells, and Epithelial Progenitor Cells of C57Bl/6 Male Mice with Metabolic Disorders


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The properties of spermatogonial stem cells, endothelial progenitor cells, and the epithelial progenitors of C57Bl/6 mice under conditions of metabolic disorders were studied using the model of busulfan-induced suppression of spermatogenesis and in vitro culture technique. Spermatogonial stem cells CD117—CD90+ and epithelial progenitors CD45—CD31—Sca-1+CD49f+ derived from the testes of mice with metabolic disturbances demonstrated 17- and 28-fold increase in the respective cell mass and generated cell colonies in vitro. In contrast, spermatogonial stem cells with immune phenotype CD51—CD24+CD52+ had reduced selfrenewal capacity. Spermatogonial stem cells CD117—CD90+ and CD117+CD90+ as well as endothelial progenitors CD45—CD31+ derived from the testes of donor mice with metabolic disorders demonstrated high transplantation capacity in C57Bl/6 mouse testes damaged by cytostatic busulfan.

Sobre autores

E. Skurikhin

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Rússia, Tomsk

A. Pakhomova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Autor responsável pela correspondência
Email: angelinapakhomova2011@gmail.com
Rússia, Tomsk

O. Pershina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Rússia, Tomsk

L. Ermolaeva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Rússia, Tomsk

V. Krupin

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Rússia, Tomsk

N. Ermakova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Rússia, Tomsk

E. Pan

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Rússia, Tomsk

A. Kudryashova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Rússia, Tomsk

O. Rybalkina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Rússia, Tomsk

T. Pavlovskaya

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Rússia, Tomsk

N. Litvyakov

Tomsk National Research Medical Center, Russian Academy of Sciences

Email: angelinapakhomova2011@gmail.com
Rússia, Tomsk

V. Goldberg

Tomsk National Research Medical Center, Russian Academy of Sciences

Email: angelinapakhomova2011@gmail.com
Rússia, Tomsk

A. Dygai

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Rússia, Tomsk

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Springer Science+Business Media, LLC, 2016